Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.35 |
| ▸ | PDE6D | O43924 | 1/20 | 0.33 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SNCA | P37840 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22595384 | 1.00 | PDK2 (0.35) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL22595369 | 1.00 | PDK2 (0.35) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL19928800 | 1.00 | PDK2 (0.35) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL22595822 | 1.00 | PDK2 (0.35) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL20318556 | 1.00 | PDK2 (0.35) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL22595835 | 1.00 | PDK2 (0.35) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL19928810 | 0.99 | PDK2 (0.34) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL22595658 | 0.99 | PDK2 (0.34) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL22596507 | 0.99 | PDK2 (0.34) | PDK2PDE6DADAMTS5CES2ALDH1A1 | |
| SCHEMBL22595815 | 0.98 | PDK2 (0.33) | PDK2PDE6DADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10941144-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2021-03-09 | — | — | US | disclosed |
| US-20180179206-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD., (JP) | 2018-06-28 | — | — | US | disclosed |
| US-20180179206-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD., (JP) | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180179206-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | L1CAM, ESR1, CHRM1 | PDK2 1466/4885PDE6D 964/4885ADAMTS5 4590/4885 |
| US-10941144-B2 | Organic electroluminescence device and electronic device | L1CAM, ESR1, CHRM1 | PDK2 1466/4885PDE6D 964/4885ADAMTS5 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.